InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
21.56
+0.17 (0.79%)
At close: Mar 9, 2026

InventisBio Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Market Capitalization
12,46915,7547,6718,7067,636-
Upgrade
Market Cap Growth
62.56%105.38%-11.89%14.01%--
Upgrade
Enterprise Value
10,95614,2416,0716,7285,265-
Upgrade
Last Close Price
21.5627.2413.3015.1413.28-
Upgrade
PS Ratio
334.07422.0845.4546.92--
Upgrade
PB Ratio
7.499.464.244.363.45-
Upgrade
P/TBV Ratio
7.499.474.244.363.45-
Upgrade
EV/Sales Ratio
293.52381.5335.9736.27--
Upgrade
Debt / Equity Ratio
0.010.010.010.010.010.04
Upgrade
Net Debt / Equity Ratio
-0.91-0.91-0.92-0.95-1.00-1.02
Upgrade
Net Debt / EBITDA Ratio
4.864.866.045.924.291.95
Upgrade
Net Debt / FCF Ratio
--6.676.084.562.52
Upgrade
Asset Turnover
--0.080.08--
Upgrade
Quick Ratio
--20.6513.2920.177.37
Upgrade
Current Ratio
--20.7813.4120.417.50
Upgrade
Return on Equity (ROE)
-18.23%-18.23%-12.61%-13.48%-33.34%-42.22%
Upgrade
Return on Assets (ROA)
---8.60%-9.08%-20.63%-24.42%
Upgrade
Return on Capital Employed (ROCE)
---15.30%-16.30%-23.20%-51.70%
Upgrade
Earnings Yield
-2.54%-2.01%-3.13%-3.26%-6.33%-
Upgrade
FCF Yield
---3.25%-3.61%-6.35%-
Upgrade
Buyback Yield / Dilution
0.07%0.07%-0.26%-12.97%-10.91%0.25%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.